z-logo
Premium
SAFETY AND EFFICACY OF MOGAMULIZUMAB IN PATIENTS WITH ADULT T‐CELL LEUKEMIA‐LYMPHOMA IN JAPAN: INTERIM RESULTS OF POSTMARKETING ALL‐CASE SURVEILLANCE
Author(s) -
Ishitsuka K.,
Yurimoto S.,
Kawamura K.,
Tsuji Y.,
Iwabuchi M.,
Takahashi T.,
Tobinai K.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2438_116
Subject(s) - medicine , neutropenia , rash , postmarketing surveillance , tumor lysis syndrome , febrile neutropenia , leukopenia , adult t cell leukemia/lymphoma , leukemia , lymphoma , adverse effect , chemotherapy , t cell leukemia

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom